A characteristic spectrum of pediatric lung-clearing and phlegm-removing oral liquid and its construction method and a detection method of multi-index components

Through high-performance liquid chromatography detection method, a characteristic map of oral liquid in children with lung clearing and phlegm was constructed, which solved the problem that the multi-index components of drugs could not be comprehensively detected in the existing technology, and achieved a comprehensive quality of oral liquid in children with lung clearing and phlegm. Accurate reflection and stability control.

CN118584018BActive Publication Date: 2024-12-06SUNFLOWER PHARMA GRP JIZHOU
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411045164.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-01
Publication Date
2024-12-06
Estimated Expiration
2044-08-01

AI Technical Summary

Technical Problem

The existing technology can only detect some components in the oral liquid of clearing lungs and relieving phlegm in children, and cannot fully reflect the overall quality of the drug. It lacks quality control methods for multi-index ingredients.

Method used

The characteristic peaks and relative retention times of ephedrine hydrochloride, rosmarinic acid, baicalin, hambain, baicalin and hambain were detected by high performance liquid chromatography detection method through C18 chromatography column and gradient elution procedure. Construct a characteristic map of oral liquid for children with lung clearance and phlegm to achieve a comprehensive and accurate reflection of the overall quality.

Benefits of technology

A map of 8 characteristic peaks is provided, which can comprehensively and accurately reflect the overall quality of the oral liquid in children with lung clearance and phlegm, ensure the quality stability, consistency and controllability of the preparation, and provide a comprehensive quality control method.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118584018B_ABST
    Figure CN118584018B_ABST
Patent Text Reader

Abstract

The present invention provides a characteristic spectrum of a pediatric lung-clearing and phlegm-removing oral liquid, a construction method thereof, and a multi-index component detection method, and relates to the technical field of drug analysis structure. The present invention provides a characteristic spectrum of a pediatric lung-clearing and phlegm-removing oral liquid, including characteristic peaks of ephedrine hydrochloride, rosmarinic acid, baicalin, wogonin, baicalein, and wogonin, and characteristic peaks with relative retention times of 1.5±0.15 and 2.3±0.23 with respect to the peak of ephedrine hydrochloride, respectively. The characteristic spectrum provided by the present invention has 8 characteristic peaks, which can comprehensively, accurately, and comprehensively reflect the overall quality of the pediatric lung-clearing and phlegm-removing oral liquid, and provide a comprehensive identification and evaluation method for the quality control of the pediatric lung-clearing and phlegm-removing oral liquid, thereby better ensuring the quality stability, consistency, and controllability of the preparation.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of analysis and detection, and in particular to a characteristic spectrum of a pediatric lung-clearing and phlegm-removing oral liquid and a construction method thereof, and a detection method for multiple index components. Background Art

[0002] Children's Qingfei Huatan Oral Liquid is a compound preparation of Chinese patent medicine made from eight medicinal materials: ephedra, peucedanum, scutellaria, stir-fried perilla seeds, gypsum, stir-fried bitter almonds, scutellaria baicalensis seeds, and bamboo shavings. Its quality control is crucial to ensure the safety and effectiveness of the drug.

[0003] Hu Yingjie (Hu Yingjie. Determination of the contents of five components in pediatric Qingfei Huatan oral liquid by HPLC [J]. Chinese Journal of Experimental Traditional Chinese Medicine, 2015, 21(13): 4.) established an HPLC method for the simultaneous determination of the contents of five components in pediatric Qingfei Huatan oral liquid, including ephedrine hydrochloride, pseudoephedrine hydrochloride, amygdalin, baicalin, and praeruptorin A. The ZORBAX SB-C 18 The chromatographic column was (4.6 mm × 250 mm, 5 μm), the mobile phase was acetonitrile-0.1% phosphoric acid aqueous solution, gradient elution, volume flow rate of 0.8 mL / min, column temperature of 35 °C, DAD detector, detection wavelength of 210 nm (ephedrine hydrochloride, pseudoephedrine hydrochloride), 225 nm (amygdalin), 277 nm (baicalin), 321 nm (purpurogenol A). However, the above method only detected five components, ephedrine hydrochloride, pseudoephedrine hydrochloride, amygdalin, baicalin and purpurogenol A, and the quality control indicators were few, which could not fully reflect the overall quality of the drug. Therefore, it is of great significance to develop a chromatographic analysis method that can comprehensively and accurately reflect the multi-index component characteristics of Xiaoer Qingfei Huatan Oral Liquid. Summary of the invention

[0004] In view of this, the purpose of the present invention is to provide a characteristic spectrum of pediatric Qingfei Huatan oral liquid and its construction method and a detection method of multi-index components. The characteristic spectrum provided by the present invention has 8 characteristic peaks, which can comprehensively, accurately and comprehensively reflect the overall quality of pediatric Qingfei Huatan oral liquid.

[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0006] The invention provides a characteristic spectrum of a pediatric lung-clearing and phlegm-removing oral liquid, comprising characteristic peaks of ephedrine hydrochloride, rosmarinic acid, baicalin, wogonin, baicalein and wogonin, and characteristic peaks whose relative retention times to the ephedrine hydrochloride peak are 1.5±0.15 and 2.3±0.23, respectively.

[0007] The present invention provides a method for constructing a characteristic spectrum of the pediatric Qingfei Huatan oral liquid described in the above technical solution, comprising the following steps:

[0008] Mix the pediatric Qingfei Huatan oral liquid with the hydrochloric acid methanol solution to obtain a test solution;

[0009] The test solution and the mixed reference solution are subjected to high performance liquid chromatography to obtain a test liquid phase spectrum and a reference liquid phase spectrum respectively;

[0010] The reference substances in the mixed reference substance solution include ephedrine hydrochloride, rosmarinic acid, baicalin, wogonin, baicalein and wogonin;

[0011] The conditions for the high performance liquid chromatography detection include: the chromatographic column is C 18 Chromatographic column; the mobile phase system includes mobile phase A and mobile phase B, the mobile phase A is methanol, and the mobile phase B is 0.1~0.15v / v% phosphoric acid aqueous solution; the elution method is gradient elution, and the procedure of the gradient elution is as follows:

[0012] 0-10min, the volume fraction of the mobile phase A increased from 5% to 10%;

[0013] 10-20 min, the volume fraction of the mobile phase A increases from 10% to 20%;

[0014] From 20 to 60 min, the volume fraction of the mobile phase A increased from 20% to 40%;

[0015] From 60 to 90 min, the volume fraction of the mobile phase A increased from 40% to 60%;

[0016] 90-120 min, the volume fraction of the mobile phase A increased from 60% to 75%;

[0017] The retention time of the liquid phase spectrum of the test sample is compared with the retention time of the liquid phase spectrum of the reference sample to obtain the characteristic spectrum of the pediatric Qingfei Huatan oral liquid.

[0018] Preferably, the conditions for the HPLC detection also include: column temperature of 25-35°C; mobile phase flow rate of 0.9-1.1 mL / min; injection volume of 5 μL; detection wavelength of 210 nm; theoretical plate number calculated based on the baicalin peak is not less than 2500.

[0019] Preferably, the volume ratio of the pediatric Qingfei Huatan oral liquid to the hydrochloric acid methanol solution is 1:5;

[0020] The volume fraction of hydrochloric acid in the hydrochloric acid methanol solution is 0.5%.

[0021] Preferably, the concentration of each reference substance in the mixed reference substance solution is 50 μg / mL, and the solvent includes methanol.

[0022] Preferably, the mixing includes ultrasonic mixing, and the ultrasonic mixing time is 30 minutes;

[0023] After the mixing, the method further comprises filtering the obtained ultrasonic system after the volume is fixed.

[0024] The present invention provides a method for detecting multiple index components in a pediatric lung-clearing and phlegm-removing oral liquid, comprising the following steps:

[0025] Mixing the test pediatric Qingfei Huatan oral liquid with the hydrochloric acid methanol solution to obtain a test sample solution;

[0026] The sample solution to be tested is subjected to high performance liquid chromatography to obtain a multi-index component test result of the pediatric Qingfei Huatan oral solution; the multi-index components include at least two of the following substances: ephedrine hydrochloride, rosmarinic acid, baicalin, wogonin, baicalein, wogonin, and the relative retention times of the peaks of ephedrine hydrochloride are 1.5±0.15 and 2.3±0.23, respectively;

[0027] The test results include qualitative test results, which are obtained by comparing the high performance liquid chromatogram of the sample solution to be tested with the characteristic spectrum of the pediatric Qingfei Huatan oral liquid described in the above technical solution;

[0028] The conditions for the high performance liquid chromatography detection include: the chromatographic column is C 18 Chromatographic column; the mobile phase system includes mobile phase A and mobile phase B, the mobile phase A is methanol, and the mobile phase B is 0.1~0.15v / v% phosphoric acid aqueous solution; the elution method is gradient elution, and the procedure of the gradient elution is as follows:

[0029] 0-10min, the volume fraction of the mobile phase A increased from 5% to 10%;

[0030] 10-20 min, the volume fraction of the mobile phase A increases from 10% to 20%;

[0031] From 20 to 60 min, the volume fraction of the mobile phase A increased from 20% to 40%;

[0032] From 60 to 90 min, the volume fraction of the mobile phase A increased from 40% to 60%;

[0033] From 90 to 120 min, the volume fraction of the mobile phase A increased from 60% to 75%.

[0034] Preferably, the conditions for the HPLC detection also include: column temperature of 25-35°C; mobile phase flow rate of 0.9-1.1 mL / min; injection volume of 5 μL; and detection wavelength of 210 nm.

[0035] Preferably, the volume ratio of the tested pediatric Qingfei Huatan oral liquid to the hydrochloric acid methanol solution is 1:5;

[0036] The volume fraction of hydrochloric acid in the hydrochloric acid methanol solution is 0.5%.

[0037] Preferably, the mixing includes ultrasonic mixing, and the ultrasonic mixing time is 30 minutes;

[0038] After the mixing, the method further comprises filtering the obtained ultrasonic system after the volume is fixed.

[0039] The present invention provides a characteristic spectrum of a pediatric lung-clearing and phlegm-removing oral liquid, including characteristic peaks of ephedrine hydrochloride, rosmarinic acid, baicalin, wogonin, baicalein and wogonin, and characteristic peaks with relative retention times of 1.5±0.15 and 2.3±0.23 with respect to the peak of ephedrine hydrochloride, respectively. The characteristic spectrum provided by the present invention has 8 characteristic peaks, which can comprehensively, accurately and comprehensively reflect the overall quality of the pediatric lung-clearing and phlegm-removing oral liquid, and provide a comprehensive identification and evaluation method for the quality control of the pediatric lung-clearing and phlegm-removing oral liquid, thereby better ensuring the quality stability, consistency and controllability of the preparation.

[0040] The present invention conducts high performance liquid chromatography detection on the test solution and the mixed reference solution of the oral liquid for clearing lungs and phlegm in children, and adopts C 18 The chromatographic column adopts a mobile phase system of methanol and 0.1-0.15 v / v% phosphoric acid aqueous solution, controls the gradient elution program, and obtains a characteristic spectrum of the pediatric Qingfei Huatan oral liquid, which has characteristic peaks of ephedrine hydrochloride, rosmarinic acid, baicalin, wogonin, baicalein and wogonin, and a total of 8 characteristic peaks with relative retention times of 1.5±0.15 and 2.3±0.23 with the peak of ephedrine hydrochloride. The method for constructing the characteristic spectrum of the pediatric Qingfei Huatan oral liquid provided by the present invention has good precision, stability and reproducibility, and provides a comprehensive identification and evaluation method for the quality control of the pediatric Qingfei Huatan oral liquid, thereby better ensuring the quality stability, consistency and controllability of the preparation.

[0041] The invention establishes a multi-index component detection method for pediatric lung clearing and phlegm-removing oral liquid, which can comprehensively and accurately detect the contents of six main effective components of ephedrine hydrochloride, rosmarinic acid, baicalin, wogonin, baicalein and wogonin in the pediatric lung clearing and phlegm-removing oral liquid, as well as two characteristic substance contents whose relative retention times with the peak of ephedrine hydrochloride are 1.5±0.15 and 2.3±0.23, respectively. The method can be used as a quality control method for the pediatric lung clearing and phlegm-removing oral liquid, can completely and accurately identify and evaluate the overall quality of the pediatric lung clearing and phlegm-removing oral liquid, can control the product quality raw materials more accurately and comprehensively, and can ensure the quality and efficacy of the product. BRIEF DESCRIPTION OF THE DRAWINGS

[0042] Figure 1HPLC spectra of the test product at 210 nm (a), 277 nm (b) and 328 nm (c);

[0043] Figure 2 The HPLC characteristic spectrum of the test sample (children's Qingfei Huatan oral liquid); wherein: peak 1 is ephedrine hydrochloride, peak 4 is rosmarinic acid, peak 5 is baicalin, peak 6 is wogonin, peak 7 is baicalein, peak 8 is wogonin, peak 2 is a characteristic peak with a relative retention time of 1.5±0.15 to ephedrine hydrochloride, and peak 3 is a characteristic peak with a relative retention time of 2.3±0.23 to ephedrine hydrochloride;

[0044] Figure 3 This is the HPLC characteristic spectrum of Ephedra;

[0045] Figure 4 It is the HPLC characteristic spectrum of ephedrine hydrochloride reference substance;

[0046] Figure 5 This is the HPLC characteristic spectrum of Scutellaria baicalensis;

[0047] Figure 6 This is the HPLC characteristic spectrum of baicalin reference substance;

[0048] Figure 7 This is the HPLC characteristic spectrum of wogonin reference substance;

[0049] Figure 8 This is the HPLC characteristic spectrum of baicalein reference substance;

[0050] Fig. 9 This is the HPLC characteristic spectrum of wogonin reference substance;

[0051] Fig.10 This is the HPLC characteristic spectrum of Perilla seeds;

[0052] Fig.11 This is the HPLC characteristic spectrum of rosmarinic acid reference substance;

[0053] Fig.12 This is the HPLC characteristic spectrum of bitter almond;

[0054] Fig.13 This is the HPLC characteristic spectrum of the seeds of Lepidium sativum;

[0055] Fig.14 This is the HPLC characteristic spectrum of bamboo shavings;

[0056] Fig.15 This is the durability chromatogram of Shimadzu LC20-AT instrument;

[0057] Fig.16 This is a chromatogram of the durability of the Dionex Ultimate3000 instrument;

[0058] Fig.17 This is a chromatogram of the durability of the Waters e2695 instrument;

[0059] Fig.18 This is the durability chromatogram of Shiseido Capcell column;

[0060] Fig.19 This is the durability chromatogram of the Cosmosil column;

[0061] Fig. 20 This is the durability chromatogram of the PICKERING column;

[0062] Fig.21 This is the durability chromatogram of the column temperature at 25°C;

[0063] Fig. 22 This is the durability chromatogram of the column temperature at 30°C;

[0064] Fig.23 This is the chromatogram of column temperature durability at 35°C;

[0065] Fig.24 The durability chromatogram is 0.9 mL / min mobile phase flow rate;

[0066] Fig.25 The durability chromatogram is 1.0 mL / min mobile phase flow rate;

[0067] Fig.26 The durability chromatogram is 1.1 mL / min mobile phase flow rate;

[0068] Fig. 27 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid for Children with batch number 151200204;

[0069] Fig.28 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid for Children with batch number 151200302;

[0070] Fig.29 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid for Children with batch number 151200303;

[0071] Fig.30 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid for Children with batch number 151200304;

[0072] Fig.31 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid for Children with batch number 151200308;

[0073] Fig.32 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid for Children with batch number 151200309;

[0074] Fig.33 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid for Children with batch number 151200310;

[0075] Fig.34 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid with batch number 151200311;

[0076] Fig.35 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid for Children with batch number 151200314;

[0077] Fig.36 This is the characteristic spectrum of the pediatric lung clearing and phlegm-removing oral liquid with batch number 151200315. DETAILED DESCRIPTION

[0078] The invention provides a characteristic spectrum of a pediatric lung-clearing and phlegm-removing oral liquid, comprising characteristic peaks of ephedrine hydrochloride, rosmarinic acid, baicalin, wogonin, baicalein and wogonin.

[0079] In the present invention, the characteristic spectrum of the pediatric Qingfei Huatan oral liquid preferably also includes characteristic peaks of substances whose relative retention times with the peak of ephedrine hydrochloride are 1.5±0.15 and 2.3±0.23, respectively.

[0080] In the present invention, peak 1 in the characteristic spectrum of the pediatric lung-clearing and phlegm-removing oral liquid is ephedrine hydrochloride, peak 4 is rosmarinic acid, peak 5 is baicalin, peak 6 is wogonin, peak 7 is baicalein, peak 8 is wogonin, peak 2 is a characteristic peak with a relative retention time of 1.5±0.15 with respect to ephedrine hydrochloride, and is a substance common in bitter almond and scutellaria baicalensis seeds, and peak 3 is a characteristic peak with a relative retention time of 2.3±0.23 with respect to ephedrine hydrochloride, and is a substance in bamboo shavings.

[0081] In the present invention, the relative retention time of the characteristic peaks of the bitter almond and the scutellaria baicalensis seed and the characteristic peak of ephedrine hydrochloride is preferably 1.5±0.15, more preferably 1.5±0.075; the relative retention time of the characteristic peak of the bamboo shavings and the characteristic peak of ephedrine hydrochloride is preferably 2.3±0.23, more preferably 2.3±0.165.

[0082] The present invention provides a method for constructing a characteristic spectrum of the pediatric Qingfei Huatan oral liquid according to the technical solution, comprising the following steps:

[0083] Mix the pediatric Qingfei Huatan oral liquid with the hydrochloric acid methanol solution to obtain a test solution;

[0084] The test solution and the mixed reference solution are subjected to high performance liquid chromatography to obtain a test liquid phase spectrum and a reference liquid phase spectrum respectively;

[0085] The reference substances in the mixed reference substance solution include ephedrine hydrochloride, rosmarinic acid, baicalin, wogonin, baicalein and wogonin;

[0086] The conditions for the high performance liquid chromatography detection include: the chromatographic column is C 18 Chromatographic column; the mobile phase system includes mobile phase A and mobile phase B, the mobile phase A is methanol, and the mobile phase B is 0.1~0.15v / v% phosphoric acid aqueous solution; the elution method is gradient elution, and the procedure of the gradient elution is as follows:

[0087] 0-10min, the volume fraction of the mobile phase A increased from 5% to 10%;

[0088] 10-20 min, the volume fraction of the mobile phase A increases from 10% to 20%;

[0089] From 20 to 60 min, the volume fraction of the mobile phase A increased from 20% to 40%;

[0090] From 60 to 90 min, the volume fraction of the mobile phase A increased from 40% to 60%;

[0091] 90-120 min, the volume fraction of the mobile phase A increased from 60% to 75%;

[0092] The retention time of the liquid phase spectrum of the test sample is compared with the retention time of the liquid phase spectrum of the reference sample to obtain the characteristic spectrum of the pediatric Qingfei Huatan oral liquid.

[0093] Unless otherwise specified, the materials and equipment used in the present invention are all commercially available products in the art.

[0094] The invention mixes the oral liquid for clearing lungs and reducing tan for children with the methanol solution of hydrochloric acid to obtain a test solution.

[0095] In the present invention, the volume fraction of hydrochloric acid in the hydrochloric acid methanol solution is preferably 0.5%.

[0096] In the present invention, the volume ratio of the pediatric lung clearing and phlegm-removing oral liquid to the hydrochloric acid methanol solution is preferably 1:5.

[0097] In the present invention, the mixing preferably includes ultrasonic mixing, the temperature of the ultrasonic mixing is preferably room temperature, and the time of the ultrasonic mixing is preferably 30 minutes.

[0098] After the mixing, the present invention preferably further comprises filtering the obtained ultrasonic system after volume adjustment, and the filtrate is the test solution. In the present invention, the volume adjustment is preferably performed using the hydrochloric acid methanol solution. In the present invention, the filtration is preferably performed through a 0.45 μm filter membrane.

[0099] After obtaining the test solution, the present invention performs high performance liquid chromatography detection on the test solution and the mixed reference solution, respectively, to obtain a test sample liquid phase spectrum and a reference liquid phase spectrum, respectively; the reference substances in the mixed reference solution include ephedrine hydrochloride, rosmarinic acid, baicalin, wogonin, baicalein and wogonin.

[0100] In the present invention, the concentration of each reference substance in the mixed reference substance solution is preferably 50 μg / mL. In the present invention, the solvent in the mixed reference substance solution preferably includes methanol.

[0101] In the present invention, the conditions for high performance liquid chromatography detection include: the chromatographic column is C 18 Chromatographic column, preferably including Shiseido Capcell chromatographic column, Cosmosil chromatographic column or PICKERING C 18 Chromatographic column; the column temperature is preferably 25-35°C, more preferably 30°C; the mobile phase system comprises mobile phase A and mobile phase B, the mobile phase A is methanol; the mobile phase B is 0.1-0.15 v / v% phosphoric acid aqueous solution, preferably 0.1-0.12 v / v% phosphoric acid aqueous solution; the mobile phase flow rate is preferably 0.9-1.1 mL / min, more preferably 1 mL / min; the elution mode is gradient elution, and the procedure of the gradient elution is shown in Table 1; the injection volume is preferably 5 μL; the detection wavelength is preferably 210 nm; the instrument used is preferably Waters e2695 chromatograph (quaternary pump, DAD detector).

[0102] Table 1 Gradient elution program

[0103]

[0104] After obtaining the liquid phase spectrum of the test sample and the liquid phase spectrum of the reference substance, the present invention compares the retention time of the liquid phase spectrum of the test sample with the retention time of the liquid phase spectrum of the reference substance to obtain the characteristic spectrum of the pediatric Qingfei Huatan oral liquid.

[0105] The present invention also provides a method for detecting multiple index components in the pediatric Qingfei Huatan oral liquid, comprising the following steps:

[0106] Mixing the test pediatric Qingfei Huatan oral liquid with the hydrochloric acid methanol solution to obtain a test sample solution;

[0107] The sample solution to be tested is subjected to high performance liquid chromatography to obtain a multi-index component test result of the pediatric Qingfei Huatan oral solution; the multi-index components include at least two of the following substances: ephedrine hydrochloride, rosmarinic acid, baicalin, wogonin, baicalein, wogonin, and the relative retention times of the peaks of ephedrine hydrochloride are 1.5±0.15 and 2.3±0.23, respectively;

[0108] The conditions for the high performance liquid chromatography detection include: the chromatographic column is C 18 Chromatographic column; the mobile phase system includes mobile phase A and mobile phase B, the mobile phase A is methanol, and the mobile phase B is 0.1~0.15v / v% phosphoric acid aqueous solution; the elution method is gradient elution, and the procedure of the gradient elution is as follows:

[0109] 0-10min, the volume fraction of the mobile phase A increased from 5% to 10%;

[0110] 10-20 min, the volume fraction of the mobile phase A increases from 10% to 20%;

[0111] From 20 to 60 min, the volume fraction of the mobile phase A increased from 20% to 40%;

[0112] From 60 to 90 min, the volume fraction of the mobile phase A increased from 40% to 60%;

[0113] From 90 to 120 min, the volume fraction of the mobile phase A increased from 60% to 75%.

[0114] In the present invention, the preparation method of the sample solution to be tested is the same as the preparation method of the test sample solution; the conditions of the HPLC detection are the same as the conditions of the HPLC detection in the process of constructing the characteristic spectrum of the pediatric Qingfei Huatan oral liquid, and they will not be repeated here.

[0115] In the present invention, the test results include qualitative test results. In the present invention, the qualitative test results are obtained by comparing the HPLC chromatogram of the sample solution to be tested with the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid described in the above technical solution.

[0116] In order to further illustrate the present invention, the characteristic spectrum of the pediatric lung clearing and phlegm-removing oral liquid and its construction method, and the detection method of multiple index components in the pediatric lung clearing and phlegm-removing oral liquid are described in detail below in combination with the embodiments, but they should not be understood as limiting the scope of protection of the present invention.

[0117] In the following embodiments,

[0118] 1. Instruments and test drugs

[0119] Instrument: Waters e2695 chromatograph (quaternary pump, DAD detector)

[0120] Reference substances: ephedrine hydrochloride (China National Institute for Food and Drug Control, batch number: 171241-201809), rosmarinic acid (China National Institute for Food and Drug Control, batch number: 111871-201706), baicalin (China National Institute for Food and Drug Control, batch number: 110715-201821), wogonin (China National Institute for Food and Drug Control, batch number: 112002-201702), baicalein (China National Institute for Food and Drug Control, batch number: 111595-201808), wogonin (China National Institute for Food and Drug Control, batch number: 111514-201706);

[0121] Reagents: Methanol was of chromatographic grade, water was deionized water, and other reagents were of analytical grade.

[0122] 2. HPLC detection conditions

[0123] Chromatographic column: PICKERING C18 (4.6×250mm, 5μm); methanol was used as mobile phase A, 0.1v / v% phosphoric acid aqueous solution was used as mobile phase B, and the gradient elution program was shown in Table 1; the mobile phase flow rate was 1mL / min; the column temperature was 30°C; the detection wavelength was 210nm; in the durability inspection process according to different brands of instruments, different specifications of chromatographic columns, and different column temperatures and flow rates, the theoretical plate number calculated according to the baicalin peak was not less than 2500.

[0124] Example 1

[0125] Selection of extraction solvent

[0126] Take Xiaoer Qingfei Huatan Oral Liquid, Ephedra, Peucedanum, Scutellaria, Fried Perilla Seed, Fried Apricot Kernel, Lepidium and Bamboo Shavings, respectively, with 50v / v% ethanol-water, 0.5v / v% hydrochloric acid aqueous solution, 0.5v / v% hydrochloric acid methanol solution as extraction solvent, and ultrasonically treat for 30min. The results show that 0.5v / v% hydrochloric acid methanol solution can extract more characteristic peak components, so 0.5v / v% hydrochloric acid methanol solution is selected as the extraction solvent.

[0127] Example 2

[0128] Selection of detection wavelength

[0129] Preparation of test solution: Accurately measure 5 mL of pediatric Qingfei Huatan oral solution (sample) and place it in a 25 mL volumetric flask, add 20 mL of 0.5 v / v% hydrochloric acid methanol solution, ultrasonically treat at room temperature for 30 min, cool to room temperature, add 0.5 v / v% hydrochloric acid methanol solution to the scale, shake well, filter through a 0.45 μm filter membrane, and the filtrate is the test solution.

[0130] Since different compounds have different maximum absorption wavelengths, the test solution was scanned at 200-400 nm using a DAD detector. Figure 1The HPLC spectra of the test sample at 210nm (a), 277nm (b) and 328nm (c) show that under the condition of 210nm, the chromatogram of the test sample has more information and the response values ​​of each chromatographic peak are more average, so 210nm is used as the measurement wavelength.

[0131] Example 3

[0132] Preparation of test solution: Accurately measure 5 mL of pediatric Qingfei Huatan oral solution (sample) and place it in a 25 mL volumetric flask, add 20 mL of 0.5 v / v% hydrochloric acid methanol solution, ultrasonically treat at room temperature for 30 min, cool to room temperature, add 0.5 v / v% hydrochloric acid methanol solution to the scale, shake well, filter through a 0.45 μm filter membrane, and the filtrate is the test solution.

[0133] Preparation of mixed reference solution: Accurately weigh reference substances of rosmarinic acid, baicalin, wogonin, baicalein, wogonin and ephedrine hydrochloride, add methanol to dissolve, and obtain a mixed reference solution with a concentration of 50 μg / mL for each reference substance.

[0134] The test solution and the mixed reference solution are respectively injected into a liquid chromatograph for HPLC detection to obtain a liquid phase spectrum of the test sample and a liquid phase spectrum of the reference substance;

[0135] The retention time of the liquid phase spectrum of the test sample is compared with the retention time of the liquid phase spectrum of the reference sample to obtain the characteristic spectrum of the pediatric Qingfei Huatan oral liquid.

[0136] Figure 2 It is the characteristic spectrum of the test solution. There are 8 characteristic peaks in the test chromatogram, among which peaks 1, 4, 5, 6, 7 and 8 should be consistent with the retention time of the corresponding reference peaks, peak 1 corresponds to the chromatographic peak of ephedrine hydrochloride reference, and is defined as peak S. The relative retention time of characteristic peaks 2 and 3 and peak S is calculated. The relative retention time should be within ±10% of the specified value, and the specified values ​​are: 1.50 (peak 2) and 2.30 (peak 3).

[0137] Example 4

[0138] Determination of characteristic peaks

[0139] Preparation of ephedrine hydrochloride reference solution: Accurately weigh the ephedrine hydrochloride reference, add methanol to dissolve, and obtain an ephedrine hydrochloride reference solution with a concentration of 50 μg / mL.

[0140] Preparation of baicalin reference solution: Accurately weigh the baicalin reference solution, add methanol to dissolve it, and obtain a baicalin reference solution with a concentration of 50 μg / mL.

[0141] Preparation of wogonin reference solution: Accurately weigh wogonin reference, add methanol to dissolve, and obtain a wogonin reference solution with a concentration of 50 μg / mL.

[0142] Preparation of baicalin reference solution: Accurately weigh the baicalin reference solution, add methanol to dissolve it, and obtain a baicalin reference solution with a concentration of 50 μg / mL.

[0143] Preparation of wogonin reference solution: Accurately weigh wogonin reference, add methanol to dissolve, and obtain a wogonin reference solution with a concentration of 50 μg / mL.

[0144] Preparation of rosmarinic acid reference solution: Accurately weigh the rosmarinic acid reference, add methanol to dissolve it, and obtain a rosmarinic acid reference solution with a concentration of 50 μg / mL.

[0145] Preparation of ephedra control medicinal material solution: weigh 1 g of ephedra control medicinal material, accurately add 25 mL of 0.5 v / v% hydrochloric acid methanol solution, ultrasonicate for 30 min, filter with quantitative filter paper, and the filtrate is the ephedra control medicinal material solution.

[0146] Preparation of Scutellaria baicalensis reference medicinal material solution: weigh 1 g of Scutellaria baicalensis reference medicinal material, accurately add 25 mL of 0.5 v / v% hydrochloric acid methanol solution, ultrasonicate for 30 min, filter with quantitative filter paper, and the filtrate is the Scutellaria baicalensis reference medicinal material solution.

[0147] Preparation of perilla seed control medicinal material solution: weigh 1 g of perilla seed control medicinal material, accurately add 25 mL of 0.5 v / v% hydrochloric acid methanol solution, ultrasonicate for 30 min, filter with quantitative filter paper, and the filtrate is the perilla seed control medicinal material solution.

[0148] Preparation of bitter almond reference medicinal material solution: weigh 1 g of bitter almond reference medicinal material, accurately add 25 mL of 0.5 v / v% hydrochloric acid methanol solution, ultrasonicate for 30 min, filter with quantitative filter paper, and the filtrate is the bitter almond reference medicinal material solution.

[0149] Preparation of the control medicinal material solution of tianlizi: weigh 1 g of tianlizi control medicinal material, accurately add 25 mL of 0.5 v / v% hydrochloric acid methanol solution, ultrasonicate for 30 min, filter with quantitative filter paper, and the filtrate is the control medicinal material solution of tianlizi.

[0150] Preparation of bamboo shavings reference medicinal material solution: weigh 1 g of bamboo shavings reference medicinal material, accurately add 25 mL of 0.5 v / v% hydrochloric acid methanol solution, ultrasonicate for 30 min, filter with quantitative filter paper, and the filtrate is the bamboo shavings reference medicinal material solution.

[0151] The test solution, each reference solution and reference medicinal material solution were subjected to HPLC detection.

[0152] Figure 3 This is the HPLC characteristic spectrum of Ephedra; Figure 4 It is the HPLC characteristic spectrum of ephedrine hydrochloride reference substance; Figure 5 This is the HPLC characteristic spectrum of Scutellaria baicalensis; Figure 6 This is the HPLC characteristic spectrum of baicalin reference substance; Figure 7 This is the HPLC characteristic spectrum of wogonin reference substance; Figure 8 This is the HPLC characteristic spectrum of baicalein reference substance; Fig. 9 This is the HPLC characteristic spectrum of wogonin reference substance; Fig.10 This is the HPLC characteristic spectrum of Perilla seeds; Fig.11 This is the HPLC characteristic spectrum of rosmarinic acid reference substance; Fig.12 This is the HPLC characteristic spectrum of bitter almond; Fig.13 This is the HPLC characteristic spectrum of the seeds of Lepidium sativum; Fig.14 The HPLC characteristic spectrum of bamboo shavings is shown in Figure 2. Figure 2~Figure 14 It can be seen that the pediatric Qingfei Huatan oral liquid has 8 characteristic peaks. After comparing with the HPLC spectra of the reference medicinal materials and the reference substance, peak 1 is ephedrine hydrochloride, peak 4 is rosmarinic acid, peak 5 is baicalin, peak 6 is wogonin, peak 7 is baicalein, peak 8 is wogonin, peak 2 is the characteristic peak of the substance found in bitter almond and scutellaria baicalensis seeds, and the relative retention time of peak 2 and ephedrine hydrochloride is 1.5±0.15, peak 3 is the characteristic peak of the substance found in bamboo shavings, and the relative retention time of peak 3 and ephedrine hydrochloride is 2.3±0.23.

[0153] Example 5

[0154] Methodological validation

[0155] 1. Durability test

[0156] With reference to the 2015 edition of the Chinese Pharmacopoeia, the durability of the method was investigated using different brands of liquid chromatographs (Shimadzu LC20-AT, Dionex Ultimate3000, Waters e2695), different brands of chromatographic columns (Shiseido Capcell, Cosmosil, PICKERING), column temperature, and flow rate.

[0157] The pediatric Qingfei Huatan oral liquid with batch number 151200204 was used as the sample to be tested.

[0158] Fig.15 This is the durability chromatogram of Shimadzu LC20-AT instrument; Fig.16 This is a chromatogram of the durability of the Dionex Ultimate3000 instrument; Fig.17 This is a chromatogram of the durability of the Waters e2695 instrument; Fig.18 This is the durability chromatogram of Shiseido Capcell column; Fig.19This is the durability chromatogram of the Cosmosil column; Fig. 20 This is the durability chromatogram of the PICKERING column; Fig.21 This is the durability chromatogram of the column temperature at 25°C; Fig. 22 This is the durability chromatogram of the column temperature at 30°C; Fig.23 This is the chromatogram of column temperature durability at 35°C; Fig.24 The durability chromatogram is 0.9 mL / min mobile phase flow rate; Fig.25 The durability chromatogram is 1.0 mL / min mobile phase flow rate; Fig.26 The durability chromatogram is 1.1 mL / min mobile phase flow rate; Figure 15~Figure 26 The results showed that the chromatographic peaks were well separated under different conditions and the common peaks were consistent, indicating that the method had good durability.

[0159] 2. Feature map verification

[0160] The 10 batches (batch numbers 151200204, 151200302, 151200303, 151200304, 151200308, 151200309, 151200310, 151200311, 151200314, and 151200315) of pediatric Qingfei Huatan oral liquid were prepared into test solutions and subjected to HPLC detection.

[0161] Fig. 27 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid for Children with batch number 151200204; Fig.28 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid for Children with batch number 151200302; Fig.29 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid for Children with batch number 151200303; Fig.30 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid for Children with batch number 151200304; Fig.31 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid for Children with batch number 151200308; Fig.32 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid for Children with batch number 151200309; Fig.33 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid for Children with batch number 151200310; Fig.34 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid with batch number 151200311; Fig.35 This is the characteristic spectrum of the Xiaoer Qingfei Huatan Oral Liquid for Children with batch number 151200314; Fig.36 The characteristic spectrum of the pediatric lung-clearing and phlegm-removing oral liquid with batch number 151200315; Figure 27 to Figure 36 It can be seen that different batches of children's lung clearing and phlegm-removing oral liquid all have characteristic peaks 1 to 8.

[0162] Although the above-mentioned embodiments have made a detailed description of the present invention, they are only some embodiments of the present invention, rather than all embodiments. People can also obtain other embodiments based on the embodiments of the present invention without creative work, and these embodiments all fall within the scope of protection of the present invention.

Claims

1. A method for constructing a characteristic spectrum of a pediatric Qingfei Huatan oral liquid, characterized in that: The following steps are involved: Mix the pediatric Qingfei Huatan oral liquid with the hydrochloric acid methanol solution to obtain a test solution; The test solution and the mixed reference solution are subjected to high performance liquid chromatography to obtain a test liquid phase spectrum and a reference liquid phase spectrum respectively; The reference substances in the mixed reference substance solution include ephedrine hydrochloride, rosmarinic acid, baicalin, wogonin, baicalein and wogonin; The conditions for the high performance liquid chromatography detection include: the chromatographic column is C 18 Chromatographic column; the mobile phase system includes mobile phase A and mobile phase B, the mobile phase A is methanol, and the mobile phase B is 0.1~0.15v / v% phosphoric acid aqueous solution; the elution method is gradient elution, and the procedure of the gradient elution is as follows: From 0 to 10 min, the volume fraction of the mobile phase A increased from 5% to 10%; 10-20 min, the volume fraction of the mobile phase A increases from 10% to 20%; From 20 to 60 min, the volume fraction of the mobile phase A increased from 20% to 40%; From 60 to 90 min, the volume fraction of the mobile phase A increased from 40% to 60%; 90-120 min, the volume fraction of the mobile phase A increased from 60% to 75%; The retention time of the liquid phase spectrum of the test sample is compared with the retention time of the liquid phase spectrum of the reference sample to obtain the characteristic spectrum of the pediatric Qingfei Huatan oral liquid.

2. The construction method according to claim 1, characterized in that: The conditions for the high performance liquid chromatography detection also include: column temperature of 25-35°C; mobile phase flow rate of 0.9-1.1 mL / min; injection volume of 5 μL; detection wavelength of 210 nm; theoretical plate number calculated based on the baicalin peak is not less than 2500.

3. The construction method according to claim 1, characterized in that: The volume ratio of the pediatric lung clearing and phlegm-removing oral liquid to the hydrochloric acid methanol solution is 1:5; The volume fraction of hydrochloric acid in the hydrochloric acid methanol solution is 0.5%.

4. The construction method according to claim 1, characterized in that: The concentration of each reference substance in the mixed reference substance solution is 50 μg / mL, and the solvent includes methanol.

5. The construction method according to claim 1 or 3, characterized in that: The mixing includes ultrasonic mixing, and the time of the ultrasonic mixing is 30 minutes; After the mixing, the method further comprises filtering the obtained ultrasonic system after the volume is fixed.

6. A method for detecting multiple index components in pediatric Qingfei Huatan oral liquid, characterized in that: The following steps are involved: Mixing the test pediatric Qingfei Huatan oral liquid with the hydrochloric acid methanol solution to obtain a test sample solution; The sample solution to be tested is subjected to high performance liquid chromatography to obtain a multi-index component test result of the pediatric Qingfei Huatan oral solution; the multi-index components include at least two of the following substances: ephedrine hydrochloride, rosmarinic acid, baicalin, wogonin, baicalein, wogonin, and the relative retention times of the peaks of ephedrine hydrochloride are 1.5±0.15 and 2.3±0.23, respectively; The test results include qualitative test results, which are obtained by comparing the high performance liquid chromatogram of the sample solution to be tested with the characteristic spectrum of the pediatric Qingfei Huatan oral liquid obtained by the construction method according to any one of claims 1 to 5; The conditions for the high performance liquid chromatography detection include: the chromatographic column is C 18 Chromatographic column; the mobile phase system includes mobile phase A and mobile phase B, the mobile phase A is methanol, and the mobile phase B is 0.1~0.15v / v% phosphoric acid aqueous solution; the elution method is gradient elution, and the procedure of the gradient elution is as follows: From 0 to 10 min, the volume fraction of the mobile phase A increased from 5% to 10%; 10-20 min, the volume fraction of the mobile phase A increases from 10% to 20%; From 20 to 60 min, the volume fraction of the mobile phase A increased from 20% to 40%; From 60 to 90 min, the volume fraction of the mobile phase A increased from 40% to 60%; From 90 to 120 min, the volume fraction of the mobile phase A increased from 60% to 75%.

7. The method for detecting multiple index components according to claim 6, characterized in that: The conditions for the high performance liquid chromatography detection also include: column temperature of 25-35°C; mobile phase flow rate of 0.9-1.1 mL / min; injection volume of 5 μL; and detection wavelength of 210 nm.

8. The method for detecting multiple index components according to claim 6, characterized in that: The volume ratio of the tested pediatric Qingfei Huatan oral liquid to the hydrochloric acid methanol solution is 1:5; The volume fraction of hydrochloric acid in the hydrochloric acid methanol solution is 0.5%.

9. The method for detecting multiple index components according to claim 6 or 8, characterized in that: The mixing includes ultrasonic mixing, and the time of the ultrasonic mixing is 30 minutes; After the mixing, the method further comprises filtering the obtained ultrasonic system after the volume is fixed.